Evidence map›Paper›PMID 29351444›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2018

Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D

Shannon H Lacy, Amali P Epa, Stephen J Pollock, Collynn F Woeller, Thomas H Thatcher, Richard P Phipps, Patricia J Sime

Abstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Protocol for differentiating primary human small airway epithelial cells at the air-liquid interface.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  3. From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Review
  4. Article
  5. Review
  6. ADAM17/PTGS2 Facilitates Pulmonary Fibrosis by Regulating Ferroptosis.Journal of cellular and molecular medicine · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Prostaglandin EAmerican journal of physiology. Lung cellular and molecular physiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shannon H LacyDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.ORCID 0000-0002-8999-4827
Amali P EpaDepartment of Pathology, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Stephen J PollockDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Collynn F WoellerDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Thomas H ThatcherLung Biology and Disease Program, University of Rochester School of Medicine and Dentistry , Rochester, New York.ORCID 0000-0001-7177-3041
Richard P PhippsDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Patricia J SimeDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
University of Rochester · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Sally W Thurston · 1985 to 2026
$42.8M
Training in Environment ToxicologyT32ES007026 · NIEHS · UNIVERSITY OF ROCHESTER · PI Alison Elder, Marissa Sobolewski Terry · 1985 to 2026
$20.2M
MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCHT32HL066988 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N, O'REILLY, MICHAEL A · 2001 to 2021
$8.1M
Novel therapies for cigarette smoke induced lung injuryR01HL120908 · NHLBI · UNIVERSITY OF ROCHESTER · PI SIME, PATRICIA JANET · 2014 to 2017
$1.6M
R01 Transfer from U. of Rochester- Lactate Promotes Scarring After IrradiationR01HL127001 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SIME, PATRICIA JANET, WILLIAMS, JACQUELINE PATRICIA · 2016 to 2019
$1.5M
NHLBI NIH HHS R01 HL120908NHLBI NIH HHS R01 HL127001NHLBI NIH HHS T32 HL066988NIEHS NIH HHS P30 ES001247NIEHS NIH HHS T32 ES007026
6 · The paper itself

Abstract

In pulmonary fibrosis (PF), fibroblasts and myofibroblasts proliferate and deposit excessive extracellular matrix in the interstitium, impairing normal lung function. Because most forms of PF have a poor prognosis and limited treatment options, PF represents an urgent unmet need for novel, effective therapeutics. Although the role of immune cells in lung fibrosis is unclear, recent studies suggest that T lymphocyte (T cell) activation may be impaired in PF patients. Furthermore, we have previously shown that activated T cells can produce prostaglandins with anti-scarring potential. Here, we test the hypothesis that activated T cells directly inhibit myofibroblast differentiation using a coculture system. Coculture with activated primary blood-derived T cells, from both healthy human donors and PF patients, inhibited transforming growth factor β-induced myofibroblast differentiation in primary human lung fibroblasts isolated from either normal or PF lung tissue. Coculture supernatants contained anti-fibrotic prostaglandins D

Indexed as

Cell DifferentiationCells, CulturedCoculture TechniquesDinoprostoneFibroblastsHumansMyofibroblastsProstaglandin D2Pulmonary FibrosisT-LymphocytesTransforming Growth Factor betaDinoprostoneProstaglandin D2Transforming Growth Factor beta

Identifiers

PMID29351444
PMCPMC5966783
OpenAlexW2780367643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.